-
There have been no major therapeutic steps added for the management of acute gouty arthritis (AGA) for over 30 years.
-
Both short (6 or fewer hours) and long (9 or more hours) habitual sleep durations predict an increased risk of weight gain in adults.
-
Early age at initiation of smoking is associated with an increased mortality risk in women. Quitting reduces the excess mortality risk for all major causes of smoking related deaths.
-
The FDA has approved a drug to help patients regain bowel function following bowel resection surgery.
-
Vasculopathy knows no compartmentalization. Clinicians expect that patients with peripheral arterial disease will also commonly have comorbid coronary or cerebrovascular disease, even though it may be silent.
-
Data from the Nurses Health Study revealed that abdominal obesity in females is significantly and positively associated with all-cause and cause-specific mortality and specifically is associated with increased CVD mortality even in normal-weight women.
-
Regadenoson, the first selective A2A adenosine receptor agonist, has been approved for use as a pharmacologic stress agent for nuclear medicine stress testing (radionuclide myocardial perfusion imaging).
-
Because the consequence of missed pulmonary embolism (PEM) is so grave, it is essential to continue our evolution of tools which maximize diagnostic sensitivity, offer clinical expedience, and minimize risk for the patient.
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
Despite previous positive reports and much lay enthusiasm, omega-3 fatty acid treatment did not prevent Crohn's disease relapse. (Arguments continue as to whether the correct usage should be "Crohn disease" or "Crohn's disease." Most of the literature seems to use the latter designation, and this review will do likewise.)
